Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Cancer Gene Therapy Market Research Report 2017

  • QYR2275214
  • 120 Pages
  • December 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the global Cancer Gene Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Gene Therapy in these regions, from 2012 to 2022 (forecast), covering

North America

Europe

China

Japan

Southeast Asia

India

Global Cancer Gene Therapy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Adaptimmune

GlaxoSmithKline

Bluebird bio

Merck

Celgene

Shanghai Sunway Biotech

BioCancell

Shenzhen SiBiono GeneTech

SynerGene Therapeutics

OncoGenex Pharmaceuticals

Genelux Corporation

Cell Genesys

Advantagene

GenVec

BioCancell

Celgene

Epeius Biotechnologies

Introgen Therapeutics

Ziopharm Oncology

Shenzhen SiBiono GeneTech

Altor Bioscience

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Gene Induced Immunotherapy

Oncolytic Virotherapy

Gene Transfer

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Hospitals

Diagnostics Centers

Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Cancer Gene Therapy Market Research Report 2017

1 Cancer Gene Therapy Market Overview

1.1 Product Overview and Scope of Cancer Gene Therapy

1.2 Cancer Gene Therapy Segment by Type (Product Category)

1.2.1 Global Cancer Gene Therapy Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)

1.2.2 Global Cancer Gene Therapy Production Market Share by Type (Product Category) in 2016

1.2.3 Gene Induced Immunotherapy

1.2.4 Oncolytic Virotherapy

1.2.5 Gene Transfer

1.3 Global Cancer Gene Therapy Segment by Application

1.3.1 Cancer Gene Therapy Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Hospitals

1.3.3 Diagnostics Centers

1.3.4 Research Institutes

1.4 Global Cancer Gene Therapy Market by Region (2012-2022)

1.4.1 Global Cancer Gene Therapy Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Cancer Gene Therapy (2012-2022)

1.5.1 Global Cancer Gene Therapy Revenue Status and Outlook (2012-2022)

1.5.2 Global Cancer Gene Therapy Capacity, Production Status and Outlook (2012-2022)

2 Global Cancer Gene Therapy Market Competition by Manufacturers

2.1 Global Cancer Gene Therapy Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Cancer Gene Therapy Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Cancer Gene Therapy Production and Share by Manufacturers (2012-2017)

2.2 Global Cancer Gene Therapy Revenue and Share by Manufacturers (2012-2017)

2.3 Global Cancer Gene Therapy Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Cancer Gene Therapy Manufacturing Base Distribution, Sales Area and Product Type

2.5 Cancer Gene Therapy Market Competitive Situation and Trends

2.5.1 Cancer Gene Therapy Market Concentration Rate

2.5.2 Cancer Gene Therapy Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Cancer Gene Therapy Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Cancer Gene Therapy Capacity and Market Share by Region (2012-2017)

3.2 Global Cancer Gene Therapy Production and Market Share by Region (2012-2017)

3.3 Global Cancer Gene Therapy Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Cancer Gene Therapy Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Cancer Gene Therapy Consumption by Region (2012-2017)

4.2 North America Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)

4.3 Europe Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)

4.4 China Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)

4.5 Japan Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)

4.7 India Cancer Gene Therapy Production, Consumption, Export, Import (2012-2017)

5 Global Cancer Gene Therapy Production, Revenue (Value), Price Trend by Type

5.1 Global Cancer Gene Therapy Production and Market Share by Type (2012-2017)

5.2 Global Cancer Gene Therapy Revenue and Market Share by Type (2012-2017)

5.3 Global Cancer Gene Therapy Price by Type (2012-2017)

5.4 Global Cancer Gene Therapy Production Growth by Type (2012-2017)

6 Global Cancer Gene Therapy Market Analysis by Application

6.1 Global Cancer Gene Therapy Consumption and Market Share by Application (2012-2017)

6.2 Global Cancer Gene Therapy Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Cancer Gene Therapy Manufacturers Profiles/Analysis

7.1 Adaptimmune

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Cancer Gene Therapy Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Adaptimmune Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 GlaxoSmithKline

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Cancer Gene Therapy Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 GlaxoSmithKline Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Bluebird bio

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Cancer Gene Therapy Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Bluebird bio Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Merck

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Cancer Gene Therapy Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Merck Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Celgene

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Cancer Gene Therapy Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Celgene Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Shanghai Sunway Biotech

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Cancer Gene Therapy Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Shanghai Sunway Biotech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 BioCancell

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Cancer Gene Therapy Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 BioCancell Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 Shenzhen SiBiono GeneTech

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Cancer Gene Therapy Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 SynerGene Therapeutics

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Cancer Gene Therapy Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 SynerGene Therapeutics Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

7.10 OncoGenex Pharmaceuticals

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Cancer Gene Therapy Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.10.4 Main Business/Business Overview

7.11 Genelux Corporation

7.12 Cell Genesys

7.13 Advantagene

7.14 GenVec

7.15 BioCancell

7.16 Celgene

7.17 Epeius Biotechnologies

7.18 Introgen Therapeutics

7.19 Ziopharm Oncology

7.20 Shenzhen SiBiono GeneTech

7.21 Altor Bioscience

8 Cancer Gene Therapy Manufacturing Cost Analysis

8.1 Cancer Gene Therapy Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Cancer Gene Therapy

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Cancer Gene Therapy Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Cancer Gene Therapy Market Forecast (2017-2022)

12.1 Global Cancer Gene Therapy Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Cancer Gene Therapy Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Cancer Gene Therapy Price and Trend Forecast (2017-2022)

12.2 Global Cancer Gene Therapy Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Cancer Gene Therapy Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Cancer Gene Therapy Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Cancer Gene Therapy Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

List of Tables and Figures

Figure Picture of Cancer Gene Therapy

Figure Global Cancer Gene Therapy Production (Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)

Figure Global Cancer Gene Therapy Production Market Share by Types (Product Category) in 2016

Figure Product Picture of Gene Induced Immunotherapy

Table Major Manufacturers of Gene Induced Immunotherapy

Figure Product Picture of Oncolytic Virotherapy

Table Major Manufacturers of Oncolytic Virotherapy

Figure Product Picture of Gene Transfer

Table Major Manufacturers of Gene Transfer

Figure Global Cancer Gene Therapy Consumption (Units) by Applications (2012-2022)

Figure Global Cancer Gene Therapy Consumption Market Share by Applications in 2016

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Diagnostics Centers Examples

Table Key Downstream Customer in Diagnostics Centers

Figure Research Institutes Examples

Table Key Downstream Customer in Research Institutes

Figure Global Cancer Gene Therapy Market Size (Million USD), Comparison (Units) and CAGR (%) by Regions (2012-2022)

Figure North America Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Cancer Gene Therapy Revenue (Million USD) Status and Outlook (2012-2022)

Figure Global Cancer Gene Therapy Capacity, Production (Units) Status and Outlook (2012-2022)

Figure Global Cancer Gene Therapy Major Players Product Capacity (Units) (2012-2017)

Table Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers (2012-2017)

Table Global Cancer Gene Therapy Capacity Market Share of Key Manufacturers (2012-2017)

Figure Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers in 2016

Figure Global Cancer Gene Therapy Capacity (Units) of Key Manufacturers in 2017

Figure Global Cancer Gene Therapy Major Players Product Production (Units) (2012-2017)

Table Global Cancer Gene Therapy Production (Units) of Key Manufacturers (2012-2017)

Table Global Cancer Gene Therapy Production Share by Manufacturers (2012-2017)

Figure 2016 Cancer Gene Therapy Production Share by Manufacturers

Figure 2017 Cancer Gene Therapy Production Share by Manufacturers

Figure Global Cancer Gene Therapy Major Players Product Revenue (Million USD) (2012-2017)

Table Global Cancer Gene Therapy Revenue (Million USD) by Manufacturers (2012-2017)

Table Global Cancer Gene Therapy Revenue Share by Manufacturers (2012-2017)

Table 2016 Global Cancer Gene Therapy Revenue Share by Manufacturers

Table 2017 Global Cancer Gene Therapy Revenue Share by Manufacturers

Table Global Market Cancer Gene Therapy Average Price (K USD/Unit) of Key Manufacturers (2012-2017)

Figure Global Market Cancer Gene Therapy Average Price (K USD/Unit) of Key Manufacturers in 2016

Table Manufacturers Cancer Gene Therapy Manufacturing Base Distribution and Sales Area

Table Manufacturers Cancer Gene Therapy Product Category

Figure Cancer Gene Therapy Market Share of Top 3 Manufacturers

Figure Cancer Gene Therapy Market Share of Top 5 Manufacturers

Table Global Cancer Gene Therapy Capacity (Units) by Region (2012-2017)

Figure Global Cancer Gene Therapy Capacity Market Share by Region (2012-2017)

Figure Global Cancer Gene Therapy Capacity Market Share by Region (2012-2017)

Figure 2016 Global Cancer Gene Therapy Capacity Market Share by Region

Table Global Cancer Gene Therapy Production by Region (2012-2017)

Figure Global Cancer Gene Therapy Production (Units) by Region (2012-2017)

Figure Global Cancer Gene Therapy Production Market Share by Region (2012-2017)

Figure 2016 Global Cancer Gene Therapy Production Market Share by Region

Table Global Cancer Gene Therapy Revenue (Million USD) by Region (2012-2017)

Table Global Cancer Gene Therapy Revenue Market Share by Region (2012-2017)

Figure Global Cancer Gene Therapy Revenue Market Share by Region (2012-2017)

Table 2016 Global Cancer Gene Therapy Revenue Market Share by Region

Figure Global Cancer Gene Therapy Capacity, Production (Units) and Growth Rate (2012-2017)

Table Global Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Table North America Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Table Europe Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Table China Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Table Japan Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Table Southeast Asia Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Table India Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Table Global Cancer Gene Therapy Consumption (Units) Market by Region (2012-2017)

Table Global Cancer Gene Therapy Consumption Market Share by Region (2012-2017)

Figure Global Cancer Gene Therapy Consumption Market Share by Region (2012-2017)

Figure 2016 Global Cancer Gene Therapy Consumption (Units) Market Share by Region

Table North America Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)

Table Europe Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)

Table China Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)

Table Japan Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)

Table Southeast Asia Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)

Table India Cancer Gene Therapy Production, Consumption, Import & Export (Units) (2012-2017)

Table Global Cancer Gene Therapy Production (Units) by Type (2012-2017)

Table Global Cancer Gene Therapy Production Share by Type (2012-2017)

Figure Production Market Share of Cancer Gene Therapy by Type (2012-2017)

Figure 2016 Production Market Share of Cancer Gene Therapy by Type

Table Global Cancer Gene Therapy Revenue (Million USD) by Type (2012-2017)

Table Global Cancer Gene Therapy Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Cancer Gene Therapy by Type (2012-2017)

Figure 2016 Revenue Market Share of Cancer Gene Therapy by Type

Table Global Cancer Gene Therapy Price (K USD/Unit) by Type (2012-2017)

Figure Global Cancer Gene Therapy Production Growth by Type (2012-2017)

Table Global Cancer Gene Therapy Consumption (Units) by Application (2012-2017)

Table Global Cancer Gene Therapy Consumption Market Share by Application (2012-2017)

Figure Global Cancer Gene Therapy Consumption Market Share by Applications (2012-2017)

Figure Global Cancer Gene Therapy Consumption Market Share by Application in 2016

Table Global Cancer Gene Therapy Consumption Growth Rate by Application (2012-2017)

Figure Global Cancer Gene Therapy Consumption Growth Rate by Application (2012-2017)

Table Adaptimmune Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Adaptimmune Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure Adaptimmune Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure Adaptimmune Cancer Gene Therapy Production Market Share (2012-2017)

Figure Adaptimmune Cancer Gene Therapy Revenue Market Share (2012-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GlaxoSmithKline Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure GlaxoSmithKline Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure GlaxoSmithKline Cancer Gene Therapy Production Market Share (2012-2017)

Figure GlaxoSmithKline Cancer Gene Therapy Revenue Market Share (2012-2017)

Table Bluebird bio Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bluebird bio Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure Bluebird bio Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure Bluebird bio Cancer Gene Therapy Production Market Share (2012-2017)

Figure Bluebird bio Cancer Gene Therapy Revenue Market Share (2012-2017)

Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure Merck Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure Merck Cancer Gene Therapy Production Market Share (2012-2017)

Figure Merck Cancer Gene Therapy Revenue Market Share (2012-2017)

Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Celgene Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure Celgene Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure Celgene Cancer Gene Therapy Production Market Share (2012-2017)

Figure Celgene Cancer Gene Therapy Revenue Market Share (2012-2017)

Table Shanghai Sunway Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Shanghai Sunway Biotech Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure Shanghai Sunway Biotech Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure Shanghai Sunway Biotech Cancer Gene Therapy Production Market Share (2012-2017)

Figure Shanghai Sunway Biotech Cancer Gene Therapy Revenue Market Share (2012-2017)

Table BioCancell Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table BioCancell Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure BioCancell Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure BioCancell Cancer Gene Therapy Production Market Share (2012-2017)

Figure BioCancell Cancer Gene Therapy Revenue Market Share (2012-2017)

Table Shenzhen SiBiono GeneTech Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Production Market Share (2012-2017)

Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Market Share (2012-2017)

Table SynerGene Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table SynerGene Therapeutics Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure SynerGene Therapeutics Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure SynerGene Therapeutics Cancer Gene Therapy Production Market Share (2012-2017)

Figure SynerGene Therapeutics Cancer Gene Therapy Revenue Market Share (2012-2017)

Table OncoGenex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table OncoGenex Pharmaceuticals Cancer Gene Therapy Capacity, Production (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)

Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Production Growth Rate (2012-2017)

Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Production Market Share (2012-2017)

Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cancer Gene Therapy

Figure Manufacturing Process Analysis of Cancer Gene Therapy

Figure Cancer Gene Therapy Industrial Chain Analysis

Table Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2016

Table Major Buyers of Cancer Gene Therapy

Table Distributors/Traders List

Figure Global Cancer Gene Therapy Capacity, Production (Units) and Growth Rate Forecast (2017-2022)

Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Cancer Gene Therapy Price (Million USD) and Trend Forecast (2017-2022)

Table Global Cancer Gene Therapy Production (Units) Forecast by Region (2017-2022)

Figure Global Cancer Gene Therapy Production Market Share Forecast by Region (2017-2022)

Table Global Cancer Gene Therapy Consumption (Units) Forecast by Region (2017-2022)

Figure Global Cancer Gene Therapy Consumption Market Share Forecast by Region (2017-2022)

Figure North America Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)

Figure North America Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table North America Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)

Figure Europe Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)

Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Europe Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)

Figure China Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)

Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table China Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)

Figure Japan Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)

Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Japan Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)

Figure Southeast Asia Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Southeast Asia Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)

Figure India Cancer Gene Therapy Production (Units) and Growth Rate Forecast (2017-2022)

Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table India Cancer Gene Therapy Production, Consumption, Export and Import (Units) Forecast (2017-2022)

Table Global Cancer Gene Therapy Production (Units) Forecast by Type (2017-2022)

Figure Global Cancer Gene Therapy Production (Units) Forecast by Type (2017-2022)

Table Global Cancer Gene Therapy Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Cancer Gene Therapy Revenue Market Share Forecast by Type (2017-2022)

Table Global Cancer Gene Therapy Price Forecast by Type (2017-2022)

Table Global Cancer Gene Therapy Consumption (Units) Forecast by Application (2017-2022)

Figure Global Cancer Gene Therapy Consumption (Units) Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370